Zealand Pharma A/S, of Copenhagen, is relocating into new corporate headquarters about 12 kilometers from its current facilities. Relocation is planned to begin in September, with the phased move of laboratories completing by the end of the year. The move will accommodate Zealand's continued workforce growth, which has been steadily increasing to support the number of clinical development programs as well as the longer-term strategic initiative for introducing commercial support, the company said.